(Q33650384)

28 July 2017

title

Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers (English)

1 reference

28 July 2017

1 reference

1 reference

U Glück

1

1 reference

28 July 2017

J O Gebbers

series ordinal

2

1 reference

28 July 2017

R Glück

series ordinal

3

1 reference

28 July 2017

language of work or name

1 reference

1 September 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

73

1 reference

28 July 2017

issue

9

1 reference

28 July 2017

page(s)

7780-7786

1 reference

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=104305

21 June 2018

Viral-Induced Rhinitis

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=104305

21 June 2018

12 December 2020

Reduction in mortality associated with influenza vaccine during 1989-90 epidemic.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=104305

Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=104305

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=104305

Regulation of IgA synthesis and immune response by T cells and interleukins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=104305

Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=104305

The role of nasopharyngeal lymphoid tissue

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=104305

Lymphocyte development from stem cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=104305

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=104305

Influenza in children. Relationship to other respiratory agents

30 October 2018

1 reference

12 December 2020

Nasal mucociliary transport, number of ciliated cells, and beating pattern in naturally acquired common colds

1 reference

12 December 2020

Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine

1 reference

12 December 2020

Immunogenicity of new virosome influenza vaccine in elderly people

1 reference

12 December 2020

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention

1 reference

12 December 2020

Identifiers

PMC publication ID

104305

1 reference

28 July 2017

1 reference